Articles

First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy

Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya;
Department of Pediatrics, Sapporo Hokuyu Hospital, Isehara;
Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine, Isehara;
Department of Pediatrics, Hyogo Children’s Hospital, Kobe;
Department of Pediatrics, Nihon University School of Medicine, Tokyo;
Division of Hematology and Oncology, Shizuoka Children’s Hospital, Toyoake;
Department of Pediatrics, Fujita Health University School of Medicine, Toyoake;
Department of Pediatrics, Jichi Medical University School of Medicine, Shimotsuke;
Department of Perinatal and Pediatric Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka;
Department of Pediatrics, Nagoya University Graduate School of Medicine, Tokyo, Japan;
Department of Pediatrics, Nagoya University Graduate School of Medicine, Tokyo, Japan;
Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya;
Department of HSCT Data Management & Biostatistics, Nagoya University Graduate School of Medicine, Tokyo, Japan;
Department of Pediatrics, Toho University School of Medicine, Tokyo, Japan
Department of Pediatrics, Nagoya University Graduate School of Medicine, Tokyo, Japan;
Vol. 99 No. 12 (2014): December, 2014 https://doi.org/10.3324/haematol.2014.109355